Skip to content
Clinical Trials – home

Regionshospitalet Viborg

Verified siteinfo

Denmark Heibergs Alle 4, 8800 Viborg, Denmark

  • 4 trials recruiting
  • Arteriosclerosis · Hypertriglyceridaemia · Acute coronary syndrome
  • Adult patients

About Specializations

Regionshospitalet Viborg in Viborg, Denmark specialises in clinical trials of conditions such as Arteriosclerosis, Hypertriglyceridaemia, Acute coronary syndrome, Acute myocardial infarction, and other specialisations. This site conducts important research.

Main research areas of the site

Neurology and Migraine Management

The medical center is at the forefront of neurology, with a particular focus on the management and treatment of migraine disorders. The center's research is dedicated to improving the quality of life for patients who suffer from migraine attacks, especially those who are unsuitable for traditional triptan therapies.

  • Acute treatment of migraine
  • Innovative therapeutic approaches
  • Patient-centered care strategies

Through rigorous clinical trials, the center is advancing the understanding of migraine pathophysiology and developing novel treatments like rimegepant, which offer new hope for patients seeking effective relief from migraine pain.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Heibergs Alle 48800 ViborgDenmark
Recruiting now
4 trials
Conditions studied
15
Partner status
Verified site

More sites in ViborgDenmark

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

13 clinical trials

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Study on Reducing Cardiovascular Disease in Type 1 Diabetes Patients Using Finerenone and Semaglutide

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Steno Diabetes Center Copenhagen

Study on the Effects of Bisoprolol and Verapamil in Patients with Non-Obstructive Hypertrophic Cardiomyopathy

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bisoprolol Fumarate
  • Sponsor:Region Midtjylland

Study on the Safety and Effectiveness of Warfarin for Patients with Atrial Fibrillation Undergoing Dialysis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Warfarin Sodium
  • Sponsor:Rigshospitalet

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting

Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.

Hypertriglyceridaemia+1

Not recruiting

Study of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 678354 sodium salt
  • Sponsor:Ionis Pharmaceuticals Inc.

Hypertriglyceridaemia

Not recruiting

Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 678354 sodium salt
  • Sponsor:Ionis Pharmaceuticals Inc.

Migraine

Not recruiting

Study on Rimegepant for Treating Migraine in Adults Who Cannot Use Triptans

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Study Comparing Rituximab and Ocrelizumab for Patients with Active Multiple Sclerosis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ocrelizumab
  • Sponsor:Rigshospitalet

Lichen sclerosus

Not recruiting

Study on the Effectiveness and Safety of MC2-25 Cream for Women with Vulvar Lichen Sclerosus

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alanyl Glutamine
  • Sponsor:Mc2 Therapeutics Limited

Cardiac arrest

Not recruiting

Study on Sodium Bicarbonate and Sodium Chloride for Patients with In-Hospital Cardiac Arrest

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Region Midtjylland
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.